Treatment with EO-3021 (SYSA1801) produced promising preliminary data in a small cohort of patients with advanced, unresectable, or metastatic gastric or gastroesophageal junction (GEJ) cancers expressing Claudin 18.2 (CLDN18.2), according […]
AstraZeneca and Daiichi Sankyo’s Enhertu (trastuzumab deruxtecan) has received conditional approval in China as a monotherapy for the treatment of adult patients with locally advanced or metastatic HER2-positive gastric or […]
Debbie’s Dream Foundation: Curing Stomach Cancer shared on LinkedIn: “New Interview Alert! Our CEO, Andrea Eidelman, sat down with OncoDaily’s Editor-in-Chief, Gevorg Tamamyan, for a powerful conversation about the mission of Debbie’s Dream Foundation: Curing […]
Gastric cancer (GC) is characterized with differentiation disorders, the precise mechanisms of which remain unknown. Our previous study showed that PHF10 exhibits oncogenic properties in GC, with its histological presentation […]
Cancer With the Help of an AACR Grant Valerie O’Brien, PhD, is using her microbiology expertise to model and study gastric cancer development with early support from a Debbie’s Dream […]
Combination therapy with evorpacept (ALX148), trastuzumab (Herceptin), ramucirumab (Cyramza), and paclitaxel (TRP) meaningfully improved overall response rate (ORR) and duration of response (DOR) compared with TRP alone among those with […]
In 2011, a Chinese research team began visiting nearly 1000 villages in Shandong province to launch an unprecedented cancer prevention experiment. A simple breath test given to more than 180,000 […]
“The National Institute for Health and Care Excellence (NICE) has recommended the use of the immunotherapy drug pembrolizumab (also known as Keytruda) as an option for people with advanced gastric […]
In a recent study published in The Lancet Public Health, researchers assessed cancer incidence and mortality trends in the United States (US). Previously, the authors reported an increased incidence of […]
Dear Friends, I am writing to you with a heartfelt request for your support. My name is Chris Gomez, and I want to share my personal story and commitment to […]
